Neovasc Inc. Notes Payable

Notes Payable of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Notes Payable growth rates and interactive chart.


Highlights and Quick Summary

  • Notes Payable for the quarter ending June 30, 2013 was $70 Thousand (a -41.67% decrease compared to previous quarter)
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Notes Payable of Neovasc Inc.

Most recent Notes Payableof NVCN including historical data for past 10 years.

Interactive Chart of Notes Payable of Neovasc Inc.

Neovasc Inc. Notes Payable for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2013 $0.07 $0.12
2012 $0.14

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.